Literature DB >> 24803480

Deprivation and faecal haemoglobin: implications for bowel cancer screening.

Jayne Digby1, Paula J McDonald2, Judith A Strachan2, Gillian Libby1, Robert J C Steele3, Callum G Fraser4.   

Abstract

OBJECTIVE: To investigate the relationship between deprivation and faecal haemoglobin concentration (f-Hb).
SETTING: Scottish Bowel Screening Programme.
METHODS: A total of 66725 men and women, aged 50 to 74, were invited to provide a single sample for a faecal immunochemical test. Deprivation was estimated using the Scottish Index of Multiple Deprivation quintiles: f-Hb was measured (OC-Sensor, Eiken, Japan) on 38439 participants. The relationship between deprivation quintiles and f-Hb was examined.
RESULTS: Median age was 60 years, 53.6% women, with 14.1%, 19.7%, 17.7%, 25.9% and 22.6% in the lowest to the highest deprivation quintiles respectively. No detectable f-Hb was found in 51.9%, ranging from 45.5% in the most deprived up to 56.5% in the least deprived. As deprivation increased, f-Hb increased (p < 0.0001). This trend remained controlling for sex and age (p < 0.001). Participants in the most deprived quintile were more likely to have a f-Hb above a cut-off of 80 µg Hb/g faeces compared with the least deprived, independent of sex and age (adjusted odds ratio 1.70, 95% confidence interval: 1.37 to 2.11).
CONCLUSIONS: Deprivation and f-Hb are related. This has important implications for selection of cut-off f-Hb for screening programmes, and supports the inclusion of deprivation in risk-scoring systems.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Colorectal cancer; deprivation; faecal haemoglobin; faecal immunochemical test; screening

Mesh:

Substances:

Year:  2014        PMID: 24803480     DOI: 10.1177/0969141314535388

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  9 in total

1.  Low Sensitivity of Fecal Immunochemical Tests (FIT) for Detection of Sessile Serrated Adenomas/Polyps Confirmed Over Clinical Setting, Geography, and FIT System.

Authors:  Craig Mowat; Jayne Digby; Judith A Strachan; Robert J C Steele; Callum G Fraser
Journal:  Dig Dis Sci       Date:  2019-05-18       Impact factor: 3.199

2.  The diagnostic accuracy of the faecal immunochemical test for colorectal cancer in risk-stratified symptomatic patients.

Authors:  N D'Souza; G Hicks; S C Benton; M Abulafi
Journal:  Ann R Coll Surg Engl       Date:  2019-11-07       Impact factor: 1.891

3.  Interval cancers in a national colorectal cancer screening programme.

Authors:  Robert Jc Steele; Greig Stanners; Jaroslaw Lang; David H Brewster; Francis A Carey; Callum G Fraser
Journal:  United European Gastroenterol J       Date:  2016-01-06       Impact factor: 4.623

4.  Association between socioeconomic deprivation and colorectal cancer screening outcomes: Low uptake rates among the most and least deprived people.

Authors:  Andrea Buron; Josep M Auge; Maria Sala; Marta Román; Antoni Castells; Francesc Macià; Mercè Comas; Carolina Guiriguet; Xavier Bessa; Xavier Castells
Journal:  PLoS One       Date:  2017-06-16       Impact factor: 3.240

5.  Alternative diagnoses and demographics associated with a raised quantitative faecal immunochemical test in symptomatic patients.

Authors:  Mark S Johnstone; Gillian Miller; Grace Pang; Paul Burton; Georgios Kourounis; Jack Winter; Emilia Crighton; David Mansouri; Paul Witherspoon; Karen Smith; Stephen T McSorley
Journal:  Ann Clin Biochem       Date:  2022-03-03       Impact factor: 2.587

Review 6.  Advances in Fecal Occult Blood Tests: the FIT revolution.

Authors:  Graeme P Young; Erin L Symonds; James E Allison; Stephen R Cole; Callum G Fraser; Stephen P Halloran; Ernst J Kuipers; Helen E Seaman
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

Review 7.  Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance.

Authors:  Marie Westwood; Shona Lang; Nigel Armstrong; Sietze van Turenhout; Joaquín Cubiella; Lisa Stirk; Isaac Corro Ramos; Marianne Luyendijk; Remziye Zaim; Jos Kleijnen; Callum G Fraser
Journal:  BMC Med       Date:  2017-10-24       Impact factor: 8.775

8.  Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?

Authors:  Eunate Arana-Arri; Isabel Idigoras; Begoña Uranga; Raquel Pérez; Ana Irurzun; Iñaki Gutiérrez-Ibarluzea; Callum G Fraser; Isabel Portillo
Journal:  BMC Cancer       Date:  2017-08-29       Impact factor: 4.430

9.  Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.

Authors:  Nigel D'Souza; Theo Georgiou Delisle; Michelle Chen; Sally Benton; Muti Abulafi
Journal:  Gut       Date:  2020-10-21       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.